GCLCi0
GCLCi0 (ONO-6428513) is a glutamate-cysteine ligase catalytic subunit (GCLC) inhibitor and ferroptosis inducer that blocks the rate-limiting step of glutathione synthesis and exerts anti-tumor activity. GCLCi0 specifically targets SMARCB1-deficient cancer cells, induces reactive oxygen species production and lipid peroxidation. In addition, GCLCi0 shows a significant synergistic effect with SLC7A11 inhibitors and Telaglenastat (HY-12248). GCLCi0 can be used in the research of smarcb1-deficient malignant rhabdoid tumors and smarcb1-deficient epithelioid sarcomas.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2926699-71-8
- 화학식: C8H15F3N2O3S
- 분자량:276.28
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2926699-71-8
-
분자량 276.28
-
화학식 C8H15F3N2O3S
-
SMILES
N[C@H](C(O)=O)CCS(=N)(CCCC(F)(F)F)=O
-
Synonyms
ONO-6428513
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- GCLCi0
- 2926699-71-8
- ONO-6428513
- GCLCi 0
- GCLCi-0
- ONO6428513
- ONO 6428513
- Ferroptosis
- ferroptotic cell death
- reactive oxygen species
- epithelioid sarcomas
- JMU-RTK-2
- malignant rhabdoid tumors
- glutathione synthesis
- mouse tumor xenograft models
- glutamate-cysteine ligase catalytic subunit
- lipid peroxidation
- SMARCB1-deficient cancer cells
- Inhibitor
- inhibitor
- inhibit